|
|
|
| Effect of Preoperative Adriamycin Combined with Cisplatin on the Expression of Puma and Survivin in Lung Cancer |
| WANG Hui |
| Department of Oncology, Yibin Second People's Hospital, Sichuan Province 644000 |
|
|
|
|
Abstract 【Objective】 To investigate the effect of preoperative doxorubicin combined with cisplatin interventional chemotherapy on puma and survivin protein expression in lung cancer tissues. 【Methods】 A total of 88 patients with lung cancer in our hospital were enrolled in the study, who were divided into two groups randomly.The two groups received radical resection of lung cancer, while the observation group received preoperative interventional therapy with adriamycin and cisplatin.The expression levels of puma and survivin in tumor tissues were compared between the two groups before and after interventional therapy. The surgical related indexes were recorded and the 3-year survival rates were compared between the two groups. 【Results】 The surgical pathology confirmed that the diameter of tumors in the observation group was significantly shorter than that in the control group, the stage of tumors in the observation group was significantly lower than that in the control group (P<0.05).There were no significant difference in operation time and the degree of differentiation between the two groups (P>0.05).The results of operation and pathology showed that the positive rate and expression level of puma protein in the observation group were higher than those in the control group, while the positive rate and expression level of survivin protein in the observation group were significantly lower than those in the control group (P<0.05).The average 3-year survival time of the observation group was significantly longer than that of the control group (P<0.05).There was no significant difference in 3-year survival rate between the two groups (P>0.05). 【Conclusion】 The preoperative interventional therapy with adriamycin and cisplatin is helpful to reduce the clinical stage and prolong the survival time of patients with lung cancer, which may be related to the regulation of puma and survivin protein levels.
|
|
Received: 21 June 2019
|
|
|
|
|
|
[1] 龙明伟,唐添祥,李俊华.不同性别肺腺癌晚期青年患者的临床特征分析[J].检验医学与临床, 2018,15(15):133-135.
[2] 赵真真,王忠敏,茅爱武.非小细胞肺癌的介入治疗现状[J].介入放射学杂志,2014,23(3):272-276.
[3] Koizumi T , Tsushima K , Tanabe T , et al. Bronchoscopy-guided cooled radiofrequency ablation as a novel intervention therapy for peripheral lung cancer[J].Respiration,2015, 90(1):47-55.
[4] 隋雨桐,迟文成,姜家康.芪杉方联合顺铂对肺癌A549细胞PI3K/AKt信号通路的影响[J].北京中医药大学学报, 2018,41(7):27-32.
[5] Shu GS , Lv F,Yang ZL,et al. Immunohistochemical study of PUMA,c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances[J].Int J Clin Oncol,2013,18(4):641-650.
[6] 杨学宁,吴一龙.实体瘤治疗疗效评价标准-RECIST[J].循证医学,2004,4(2):85-90.
[7] 李岚.非小细胞肺癌患者化疗前后血清多种指标水平的变化及临床意义[J].临床肺科杂志,2018,23(1):178-181.
[8] 毛一之,符祥杰,梁克,等.中央型肺鳞癌行选择性支气管动脉灌注化疗术的临床效果[J].中国医师杂志, 2018, 20(8):1155-1158.
[9] Wood, Douglas E . National Comprehensive Cancer Network (NCCN) clinical practice guidelines for lung cancer screening[J].Thorac Surg Clin,2015,25(2):185-197.
[10] 张高宽,王漠,李平,等.阿霉素联合顺铂对人胃癌组织增殖和凋亡影响作用的研究[J].临床和实验医学杂志, 2016,15(5):442-445.
[11] 赵文思,吴薇,任东明,等.阿霉素联合顺铂诱导宫颈癌细胞凋亡实验研究[J].生物技术,2013,23(1):67-70.
[12] 陈斌,陈余清,李伟.肺腺癌细胞A549中人survivin基因核心启动子位置与功能初探[J].肿瘤学杂志,2008,14(11):867-871.
[13] 张雪松,王魁阳,王利菊,等.介入化疗对肺癌患者术后病理组织血管生成和凋亡蛋白表达的影响[J].中国临床药理学杂志, 2018,34(6):629-632. |
|
|
|
2020, Vol. 37 
